Most nasal sprays are cleared from the nasal cavity and ingested within 15-20 minutes. This barrier limits the feasibility of nasal sprays to select therapies. Based on a new platform technology of sprayable hydrogels, Naris Therapeutics is able to deliver therapies that stay localised to the nasal ...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2020 (6 years)
Address:
SYDNEY, AU
LOW
spending power